奥翔药业(603229.SH)：已累计回购0.63%股份

Core Viewpoint - Aoxiang Pharmaceutical (603229.SH) has announced the completion of a share buyback program, indicating a strategic move to enhance shareholder value and confidence in the company's future prospects [1] Summary by Relevant Categories Share Buyback Details - As of August 31, 2025, the company has repurchased a total of 5,201,200 shares through centralized bidding, which represents 0.63% of the company's total share capital [1] - The highest price paid for the shares was 11.39 CNY per share, while the lowest price was 7.52 CNY per share [1] - The total amount spent on the buyback, excluding transaction fees, is 50,006,023.36 CNY [1]